These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7530355)

  • 1. Hepatitis B carriers.
    Sloan DS
    N Z Med J; 1994 Dec; 107(991):515. PubMed ID: 7530355
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the chronic hepatitis B carrier.
    Smith BC; Watson KJ
    Aust Fam Physician; 1995 Mar; 24(3):331-9. PubMed ID: 7717895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus.
    Milne A; Hopkirk N; Lucas CR; Waldon J; Foo Y
    N Z Med J; 1994 Jun; 107(980):243. PubMed ID: 8208497
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmapheresis of hepatitis B surface antigen carriers.
    Milich DR; Vyas GN; Holland PV; Couroucé-Pauty AM; Sampliner RE
    Acta Haematol Pol; 1980; 11(2):73-8. PubMed ID: 7424484
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of hepatitis B virus carrier state with nephrotic syndrome treated with beta interferon].
    Kawarazaki N; Sano K; Hayashishita N; Mitani S; Saga M; Karino Y; Sugawara S; Yoshida J; Matsushima T; Miyazaki T
    Nihon Naika Gakkai Zasshi; 1990 May; 79(5):682-3. PubMed ID: 2380616
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors influencing response to interferon in chronic hepatitis B: implications for Asian and western populations.
    Perrillo RP
    Hepatology; 1990 Dec; 12(6):1433-5. PubMed ID: 1701755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment problems in chronic hepatitis].
    Chernev K
    Vutr Boles; 1982; 21(1):6-12. PubMed ID: 6178223
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for hepatocellular carcinoma (HCC) in a hepatitis B carrier.
    Tan CK; Ng HS
    Singapore Med J; 1998 May; 39(5):229-30. PubMed ID: 9713232
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview of hepatitis B and transplantation in the hepatitis B patient.
    Garcia G; Petrovic LM; Vierling JM
    Semin Liver Dis; 2000; 20 Suppl 1():3-6. PubMed ID: 10895437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of liver neoplasms].
    Moriwaki H
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():63-6. PubMed ID: 11989264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?].
    Brenard R; Closon ML; Fevery J; Hautekeete M
    Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538
    [No Abstract]   [Full Text] [Related]  

  • 14. [The managements for asymptomatic carrier of hepatitis B virus].
    Kuroki T; Nishiguchi S; So K; Harihara S
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):420-6. PubMed ID: 12442420
    [No Abstract]   [Full Text] [Related]  

  • 15. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.
    Bortolotti F; Guido M; Bartolacci S; Cadrobbi P; Crivellaro C; Noventa F; Morsica G; Moriondo M; Gatta A
    Hepatology; 2006 Mar; 43(3):556-62. PubMed ID: 16496323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
    Chu CM; Liaw YF
    Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should healthy carriers of HBs antigen be followed-up?].
    Zylberberg H; Pol S
    Gastroenterol Clin Biol; 1996; 20(10):727-9. PubMed ID: 8991140
    [No Abstract]   [Full Text] [Related]  

  • 19. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical features of HBV asymptomatic carrier, and management].
    Miyasaka A; Suzuki K
    Nihon Rinsho; 2011 May; 69 Suppl 4():434-9. PubMed ID: 22096957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.